Asston Pharmaceuticals Limited concluded its seventh Annual General Meeting (AGM) on September 29, 2026, with shareholders approving all six agenda items unanimously. The final voting results, submitted to BSE Limited on October 1, 2026, confirm that every resolution received 100% votes in favour, with zero votes against or invalid.
The meeting, conducted via Video Conferencing/Other Audio Visual Means, saw shareholders vote on critical corporate resolutions including the appointment of statutory auditors and revisions to director remuneration. Key approvals included the adoption of audited financial statements for the fiscal year ended March 31, 2026, and the reappointment of Mr. Ashish Narayan Sakalkar as Managing Director.
Resolutions Passed at the AGM
Shareholders voted on both ordinary and special resolutions through remote e-voting and instant voting during the meeting. The following table summarizes the key agenda items put to vote and their outcomes:
| Item No. |
Agenda Description |
Type |
Votes in Favour |
Votes Against |
| 1 |
Adopt audited financial statements for FY26 |
Ordinary |
4,597,509 |
0 |
| 2 |
Appoint Mr. Ashish Narayan Sakalkar (MD) retiring by rotation |
Ordinary |
2,744,653 |
0 |
| 3 |
Approve appointment of M/s Panchal S K & Associates as statutory auditors |
Ordinary |
4,597,509 |
0 |
| 4 |
Approve increase in remuneration of Mr. Ashish Narayan Sakalkar |
Special |
285,029 |
0 |
| 5 |
Approve increase in remuneration of Mrs. Saili Jayaram More |
Special |
285,029 |
0 |
| 6 |
Approve increase in remuneration of Mr. Sachin Chandrakant Badakh |
Special |
285,029 |
0 |
Auditor Appointment Details
The shareholders approved the appointment of M/s Panchal S K & Associates as the Statutory Auditors of the company. The firm was initially appointed by the Board of Directors on September 4, 2026, and subsequently ratified by members during the AGM.
M/s Panchal S K & Associates, established in 2017 with ICAI Registration No. 145989W, is led by founder partner Swati Panchal. The firm focuses on technology-driven practices and serves clients across SMEs and larger corporates. The appointment was made under the provisions of the Companies Act, 2013, following a resolution passed by the Board.
Managing Director Re-appointment Profile
Mr. Ashish Narayan Sakalkar was re-appointed as Managing Director pursuant to Section 152(6) of the Companies Act, 2013, having retired by rotation. He holds DIN 06601011 and is not related to any other directors of the company.
Mr. Sakalkar, aged 50 years, holds a Master of Science from NMU Jalgaon and a PhD from JJT University. He also possesses a Diploma in Regulatory Affairs from the University of Delhi. His professional experience spans Industrial Chemistry, Quality Assurance, and Regulation, with a focus on business expansion and supplier negotiation.
Meeting Proceedings and Attendance
The meeting commenced at 12:30 pm with a quorum present. Mr. Rishi Upadhaya, Company Secretary and Compliance Officer, welcomed attendees and briefed them on the virtual participation guidelines issued by the Ministry of Corporate Affairs and SEBI. Mr. Ashish Narayan Sakalkar chaired the proceedings.
The Company Secretary noted that no shareholder emails were received requesting registration as speakers for the meeting. Any prior questions submitted by shareholders had already been addressed via email to their registered addresses.
Voting Mechanism and Scrutiny
Remote e-voting was available from September 26, 2026, at 9:00 am until September 28, 2026, at 5:00 pm. Members who did not vote remotely could cast their votes instantly during the AGM via the NSDL platform. Ms. Pragya Jain, a Practicing Company Secretary, served as the Scrutinizer to ensure fair and transparent vote counting.
The combined voting results, along with the Scrutinizer's report, were declared on September 30, 2026. These results have been published on the company's website and communicated to BSE Limited in compliance with Listing Regulations.
What the Numbers Show
A distinct pattern emerges in the voting data regarding director remuneration. For Items 4, 5, and 6, which involved increases in pay for the Managing Director, Whole Time Director/CEO, and Non-Executive Director respectively, the promoters and promoter group abstained entirely from voting. This resulted in only 285,029 votes being polled, representing just 3.35% of total outstanding shares, compared to over 4.5 million votes for other agenda items. This indicates that the approval for these specific pay hikes was driven solely by public non-institutional shareholders, reflecting standard corporate governance protocols where interested parties refrain from voting on their own compensation.